| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 1968032 | Clinica Chimica Acta | 2006 | 6 Pages | 
Abstract
												Pioglitazone inhibited the upregulation of LOX-1 on HUVECs elicited by oxLDL and subsequently decreased HUVECs CD40/CD40L expression induced by oxLDL. These observations provided novel insight into a potential novel anti-inflammatory pathway of thiazolidinediones.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Biochemistry
												
											Authors
												De-qian Jiang, Luo-xiang Chu, Zhao-yun Liu, Shun-bao Zhang, 
											